Abstract
Objectives
Evaluation of sarcopenia from computed tomography (CT) is often based on measuring skeletal muscle area on a single transverse slice. Automatic segmentation of muscle volume has a lower variance and may be a better proxy for the total muscle volume than single-slice areas. The aim of the study was to determine which abdominal and thoracic anatomical volumes were best at predicting the total muscle volume.
Methods
A cloud-based artificial intelligence tool (recomia.org) was used to segment all skeletal muscle of the torso of 994 patients who had performed whole-torso CT 2008–2020 for various clinical indications. Linear regression models for several anatomical volumes and single-slice areas were compared with regard to predicting the total torso muscle volume.
Results
The muscle volume from the tip of the coccyx and 25 cm cranially was the best of the abdominal volumes and was significantly better than the L3 slice muscle area (R2 0.935 vs 0.830, P < 0.0001). For thoracic volumes, the muscle volume between the top of the sternum to the lower bound of the Th12 vertebra showed the best correlation with the total volume, significantly better than the Th12 slice muscle area (R2 0.892 vs 0.775, P < 0.0001). Adjusting for body height improved the correlation slightly for all measurements but did not significantly change the ordering.
Conclusions
We identified muscle volumes that can be reliably segmented by automated image analysis which is superior to single slice areas in predicting total muscle volume.
Keywords: Image analysis (computer-assisted), Body composition, Sarcopenia, Artificial intelligence
1. Introduction
Sarcopenia, ie, reduction of muscle mass with loss of muscle function, is associated with an increased risk of postoperative complications and shorter survival in several types of cancer surgery [[1], [2], [3], [4]]. One of the ways to identify sarcopenia is to use computed tomography (CT) examinations, where the most common method is to use the muscle area at a cross-section of lumbar vertebra 3 (L3) or thoracic vertebra 12 (Th12), for which cut-off thresholds have been proposed [[5], [6], [7], [8], [9]]. This has generally been done manually by radiologists in the studies. However, due to resource and time consumption, it has rarely been established in clinical use. Moreover, the relationship between one cross section and the total muscle mass carries significant uncertainty on an individual basis.
The development of Artificial Intelligence (AI) has opened possibilities to automatically calculate the muscle area on CT in a very safe way, both more time-efficient and requiring fewer personnel resources. Commercially available solutions exist that measure the cross section skeletal muscle area [[10], [11], [12], [13]], but they still require some manual input and their clinical use have been limited. We have previously developed and described a cloud-based AI image analysis tool, the Research Consortium for Medical Image Analysis (RECOMIA). The website (recomia.org) can automatically measure skeletal muscle volume derived from CT scans and have shown that muscle volume has a lower variance than muscle area in L3 [14,15]. However, there is a lack of studies on which volume segments best correlate with the total muscle volume, and whether they are better than Th12/L3 as proxies of the total volume. Defining such optimal partial volumes would allow a better estimation of total muscle volume and sarcopenia from any CT scan of the abdomen or thorax. The goal of this study was to identify partial volumes, on CT of the thorax and of the abdomen, which correlate best with the total muscle volume and whether they perform better than Th12 or L3 slices.
2. Methods
2.1. Patient background and study design
The CT scans of the entire torso of patients who had undergone positron emission tomography/computed tomography (PET/CT) scans for various clinical indications at Sahlgrenska University Hospital in Gothenburg and Skåne University Hospital in Lund/Malmö from 2008 to 2020 were uploaded to the cloud-based AI image analysis tool Recomia.org. The majority were patients with prostate cancer (60%). The rest had lymphoma (20%), neuroendocrine cancer (10%) and other (10%). All patients were of legal age (18 years) at the time of imaging. Patients whose arms were alongside the body were excluded from analysis. The PET/CT scanners used for obtaining the CT images were from GE Healthcare Systems (models Discovery 690 and Discovery MI) and Siemens (models Biograph 64, Biograph 128 and Biograph 128 Edge).
Using the CT examinations for evaluating AI-based image analysis was approved by the Swedish Ethics Review Authority (2016/417 and 2021-05734-02).
2.2. Management of image material
During image uploading, all identifying information was automatically stripped from the digital imaging and communications in medicine (DICOM) tags of the scans. Some non-identifying patient information such as sex, age, height, and weight were preserved and later retrieved from the DICOM tags. All analysis was performed on anonymized data. Segmentation of the skeletal muscle tissue was done automatically by the AI tool without any manual intervention. The AI has also been trained to identify all the specific anatomical landmarks used in this study without the need for human input. One of the authors (TY) performed a visual inspection of a random selection of 50 of the cases to ensure that the volume segmentation was adequate and correct. The segmentations were classified as either correct or not. The AI-based image analysis has previously been described in detail and takes about 1 min per patient on a high-end desktop computer [14].
2.3. Selection of muscle volume
The cranial limit of the segmentation was the top of the sternum. ‘Sacrum and Coccyx’ was automatically segmented at the same time as muscle and fat, the most inferior slice of the automatic segmentation of coccyx was selected as the caudal limit. The volume of all skeletal muscle tissue between these reference points formed the total torso muscle volume used as reference in this study.
The cross-sectional areas of Th12 and L3 were measured because these are often used as proxies for the total muscle volume. There is lack of standardization and consensus at which part of the vertebra the cross-sectional area should be measured, here we chose to measure the area at the “center of mass” of vertebra Th12 and L3, respectively.
The pre-specified muscle volumes for abdominal CT scans that were analyzed were the volume between the tip of the coccyx and 25 cm cranially (Sacrum 25 cm), and the volume between the tip of the coccyx and the cranial limit of the first lumbar vertebra (Sacrum–L1). For thoracic CT scans the volumes were between the cranial border of the sternum and 25 cm caudally (Sternum 25 cm), the cranial border of the sternum to the caudal limit of the 12th thoracic vertebra (Sternum–Th12), and the cranial limit of 10th thoracic vertebra to the caudal limit of the 12th thoracic vertebra (Th10–12). The 25 cm volumes (Sacrum 25 cm and Sternum 25 cm) were chosen based on our previous studies on abdominal and thoracic CT scans, where 25 cm from the respective level represented the largest volumes that were consistently represented in clinical CT scans. Sacrum–L1 and Sternum–Th12 were similarly chosen to maximize the evaluated volume, while also taking the build of each patient into account.
2.4. Statistical analysis
For each of the measured areas and volumes, univariable linear regression analysis was done to predict the total torso muscle volume. For each such model, the Akaike Information Criterion (AIC), root mean squared error (RMSE) and R2 were calculated and analyzed for goodness-of-fit. The regression analyses were first performed for all patients. In a second analysis, both univariable and multivariable, also including the body height and the interaction between the volume/area and body height was done for the patients who had body height data. To evaluate the resulting models for patients of different ages, the patients were divided into quartiles. Further, correlation analysis was performed for each area or volume with regard to the total torso muscle volume, which was compared using the method described by Hittner et al. [16].
Scatter plots of the predicted total torso muscle volumes compared to the actual measured volume for each regression model was done, as well as Bland-Altman diagrams [17] for visual comparison.
Mean and standard deviation (SD) was calculated for each descriptive continuous variable. All statistical analysis was done using R version 3.6.3 (R Foundation for Statistical Computing, Vienna, Austria) with the packages tidyverse 1.3.1 and cocor 1.1–3.
3. Results
A total of 1164 patients were included in the study. Of these, 170 were excluded due to the arms being held alongside the body, leaving 994 for analysis. Manual inspection of 50 randomly selected muscle segmentations did not show any that were obviously erroneous and did not lead to any exclusions (Fig. 1). The study group thus consisted of 821 (83%) men and 173 (17%) women, with a mean age of 64 years (SD 14) and a mean body length of 176 cm (SD 8) (Table 1). Intravenous contrast had been administered in 546 (55%) of the scans.
Table 1.
Characteristic | Overall | No height | With height | |
---|---|---|---|---|
N = 994 | N = 210 | N = 784 | ||
Age, yrs | 64 (14) | 51 (17) | 68 (10) | |
Female | 173 (17%) | 87 (41%) | 86 (11%) | |
Male | 821 (83%) | 123 (59%) | 698 (89%) | |
Height, m | 1.76 (0.08) | 1.76 (0.08) | ||
Weighta, kg | 83 (16) | 78 (17) | 85 (16) | |
BMI, kg/m2 | 27.2 (4.4) | 27.2 (4.4) | ||
Manufacturer | ||||
SIEMENS | 311 (31%) | 206 (98%) | 105 (13%) | |
GE Medical Systems | 683 (69%) | 4 (2%) | 679 (87%) | |
kVp | 80 | 8 (0.8%) | 0 (0%) | 8 (1.0%) |
100 | 325 (33%) | 2 (1.0%) | 323 (41%) | |
120 | 661 (66%) | 208 (99%) | 453 (58%) | |
Slice Thickness, mm | 2.5 | 197 (20%) | 1 (0.5%) | 196 (25%) |
3 | 312 (31%) | 206 (98%) | 106 (13%) | |
5 | 485 (49%) | 3 (1.4%) | 482 (61%) | |
Intravenous contrast | 546 (55%) | 3 (1.4%) | 543 (69%) |
BMI, body mass index; kVp, kilovoltage peak.
Weight were missing in 3 of the patients in the “No height” group.
On analyzing all 994 patients, Sacrum 25 cm showed the highest correlation of the abdominal measures on all analyses, with an R2 of 0.935 (Table 2). This was significantly higher than the L3 slice muscle area (R2 0.830, P < 0.0001). For thoracic measures, Sternum–Th12 showed the highest correlation with total torso muscle volume, with an R2 of 0.892 which was significantly higher than the Th12 slice muscle area (R2 0.775, P < 0.0001). The latter was marginally higher than Sternum 25 cm with an R2 of 0.891, but this difference was not statistically significant (P = 0.16).
Table 2.
All patients (N = 994) | Patients with body height data (N = 784) | ||||||
---|---|---|---|---|---|---|---|
AIC | R2 | RMSE | AIC | R2 | RMSE | ||
Abdomen | |||||||
Sacrum 25 cm | 15,368 | 0.935 | 549 | Sacrum 25 cm | 12,151 | 0.922 | 559 |
Sacrum 25 cm with height | 12,052 | 0.932 | 524 | ||||
Sacrum - L1 | 15,718 | 0.907 | 655 | Sacrum - L1 | 12,445 | 0.887 | 675 |
Sacrum - L1 with height | 12,421 | 0.890 | 663 | ||||
L3 | 16,321 | 0.830 | 887 | L3 | 12,883 | 0.802 | 892 |
L3 with height | 12,716 | 0.840 | 800 | ||||
Thorax | |||||||
Sternum 25 cm | 15,882 | 0.891 | 711 | Sternum 25 cm | 12,557 | 0.869 | 725 |
Sternum 25 cm with height | 12,237 | 0.913 | 589 | ||||
Sternum-Th12 | 15,875 | 0.892 | 709 | Sternum-Th12 | 12,504 | 0.878 | 701 |
Sternum-Th12 with height | 12,313 | 0.905 | 619 | ||||
Th10–Th12 | 16,440 | 0.809 | 942 | Th10–Th12 | 12,986 | 0.774 | 953 |
Th10–Th12 with height | 12,872 | 0.805 | 883 | ||||
Th12 | 16,603 | 0.775 | 1022 | Th12 | 13,069 | 0.749 | 1004 |
Th12 with height | 12,817 | 0.819 | 853 |
AIC, Akaike information criterion; RMSE, root mean squared error; L3, level of the third lumbar vertebra; Th10, level of the 10th thoracic vertebra; Th12, level of the 12th thoracic vertebra.
For the 784 patients where body length was available, for abdominal scans the multivariable model including Sacrum 25 cm improved only slightly (R2 0.932 vs 0.922, P < 0.0001). In contrast, for thoracic scans, the multivariable model that included Sternum 25 cm improved markedly (R2 0.913 vs 0.869, P < 0.0001) and became similar to the multivariable model that included Sternum–Th12 (R2 0.913 vs 0.905, P = 0.05). A cross table of differences in correlations is presented in Table 3. All the evaluated volumes, except Th10–Th12, showed a significantly higher correlation with the total torso muscle volume than the single-slice areas, whether they were adjusted for body height or not (all P < 0.01; Supplemental Table 1). AIC and RMSE showed the same order of correlation as R2 for both univariable and multivariable models. Scatterplots of the respective measures against the total torso muscle volume visually demonstrate the same results (Fig. 2), as do the Bland-Altman plots (Fig. 3). Analyzing scans of male (N = 698) and female patients (N = 86) separately showed the same ordering of correlation of the models and yielded similar R2 in both groups (Sacrum 25 cm with height R2 0.897 for men and 0.920 for women, P = 0.26 with Fisher's z method; Sternum 25 cm with height R2 0.870 for men and 0.892 for women, P = 0.39). The parameters of all the regression models are shown in Supplemental Table 2. Evaluating the models for different age groups showed similar results for all age groups (Supplemental Table 3).
Table 3.
L3 | L3 with height | Sacrum - L1 | Sacrum - L1 with height | Sacrum 25 cm | Sacrum 25 cm with height | Sternum-Th12 | Sternum-Th12 with height | Sternum 25 cm | Sternum 25 cm with height | Th10–Th12 | Th10–Th12 with height | Th12 | Th12 with height | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L3 | – | 0.021 | 0.046 | 0.048 | 0.065 | 0.070 | 0.041 | 0.055 | 0.037 | 0.060 | −0.016 | 0.002 | −0.030 | 0.009 |
L3 with height | – | 0.025 | 0.027 | 0.043 | 0.048 | 0.020 | 0.034 | 0.015 | 0.039 | −0.037 | −0.019 | −0.051 | −0.012 | |
Sacrum - L1 | – | 0.002 | 0.019 | 0.024 | −0.005 | 0.009 | −0.009 | 0.014 | −0.062 | −0.044 | −0.076 | −0.037 | ||
Sacrum - L1 with height | – | 0.017 | 0.021 | −0.007 | 0.007 | −0.011 | 0.012 | −0.064 | −0.046 | −0.078 | −0.039 | |||
Sacrum 25 cm | – | 0.005 | −0.023 | −0.009 | −0.028 | −0.004 | −0.080 | −0.062 | −0.095 | −0.055 | ||||
Sacrum 25 cm with height | – | −0.028 | −0.014 | −0.033 | −0.009 | −0.085 | −0.067 | −0.100 | −0.060 | |||||
Sternum-Th12 | – | 0.014 | −0.005 | 0.019 | −0.057 | −0.039 | −0.071 | −0.032 | ||||||
Sternum-Th12 with height | – | −0.019 | 0.005 | −0.071 | −0.053 | −0.085 | −0.046 | |||||||
Sternum 25 cm | – | 0.023 | −0.052 | −0.035 | −0.067 | −0.027 | ||||||||
Sternum 25 cm with height | – | −0.076 | −0.058 | −0.090 | −0.051 | |||||||||
Th10–Th12 | – | 0.018 | −0.014 | 0.025 | ||||||||||
Th10–Th12 with height | – | −0.032 | 0.007 | |||||||||||
Th12 | – | 0.039 | ||||||||||||
Th12 with height | – |
4. Discussion
In this study, we found that the total torso muscle volume could be accurately estimated by automatic muscle segmentation of specific anatomically defined volumes on abdominal or thoracic CT scans, and that these volumes performed better than the commonly used single transverse cross-sectional muscle areas at L3 or Th12, whether adjusting for body length or not.
For abdominal CT scans, we found that the muscle volume between the tip of the coccyx and 25 cm cranially was the best at predicting the total torso muscle volume across all measures of goodness-of-fit. In their seminal paper, Shen and co-workers showed that the cross-sectional area at L3 was the best at predicting total muscle volume, with an R2 of 0.855. These results were later replicated by, eg, Schweitzer and co-workers, with an R2 of 0.76 in men but only 0.71 in women [7]. Similarly, we found an R2 of 0.830 for L3, although that was in relation to the total torso muscle volume, ie, not including the muscle volume of the extremities. While R2 is not directly comparable across studies, the similar results suggest that the improvement in prediction by measuring the Sacrum 25 cm volume rather than only a single cross section area is valid in general. In addition, we have previously reported that the pre-operative muscle volume in Sacrum 25 cm is an independent predictor of overall survival in patients who undergo radical cystectomy for urinary bladder cancer [1].
For thoracic CT scans, we found that the volume between the top of the sternum and the lower bound of the 1st lumbar vertebra was the best at predicting the total torso muscle value, although the top of the sternum and 25 cm caudally was essentially equally good. Both were significantly better than the single slice area at Th12, but also slightly worse than the best abdominal volume measure. To the best of our knowledge, no previous study has compared thoracic single-slice cross-sectional muscle areas to the total muscle volume, only comparisons to L3 slices or reference ranges in relation to L3 slices have been made [18,19]. Matsuyama and co-workers found a correlation coefficient of 0.804 between L3 and Th12 slices. We did not calculate the correlation between these slices but did find that Th12 had a worse correlation with the total torso muscle volume than L3. This agrees with the previously mentioned study by Shen and co-workers where a slice 15 cm above the L4-L5 disc was evaluated and which was worse than L3.
A recent meta-analysis has shown that lean muscle mass is a strong predictor of mortality in different forms of cancer [4]. This was also found in our previous report on mortality after radical cystectomy for bladder cancer [1]. Most studies, however, have used L3 single slices which we have shown here are less correlated to the total muscle volume than the partial volumes evaluated. Thereby, using automated segmentation of these volumes could allow a more accurate individual prediction of risks involved for the patients. However, cutoff values for sarcopenia will need to be established for these partial volumes [20].
The main strength of this study is the large number of whole-torso CT scans included. This was made possible by the automatic segmentation performed by cloud-based imaging analysis tool at Recomia.org. The main limitation is that we could not use total muscle volume as reference since the CT scans did not consistently include the extremities. Instead, we chose total torso muscle volume as a proxy, which may not entirely correlate with the total muscle volume. The similar R2 between the references we used and that of Shen and others with regard to L3 muscle area suggest that this may be a small limitation, but further validation is warranted. Another limitation is that we do not have any clinical data to correlate our findings, it is therefore difficult to set reference values as we do not know which patients actually suffer from sarcopenia. In addition, we did not visually inspect all the automatic segmentations, leaving a risk that there may be faulty segmentations that could distort the results. However, in the random 5% sample that was inspected no aberrant segmentations were detected, suggesting that the effect of faulty segmentations is likely small. Finally, a very large majority of the CT scans included in the study were made in men due to a large proportion of the patients had performed PET/CT scans for evaluation of prostate cancer. Analyzing females separately showed results very similar to the group as a whole, however, so this limitation seems to be small.
5. Conclusions
The skeletal muscle volumes Sacrum 25 cm, Sternum 25 cm and Sternum–Th12 are more accurate as proxies of total muscle volume than the single-slice areas commonly used, especially if combined with patient body height. These volumes can easily be measured through the cloud-based image analysis tool Recomia.org. Further studies are needed to define thresholds for clinical applications.
CrediT author statement
Thomas Ying: Formal analysis, Data Curation, Writing - Original Draft, Writing - Review & Editing. Pablo Borrelli: Methodology, Validation, Writing - Review & Editing. Lars Edenbrandt: Conceptualization, Writing - Review & Editing, Funding acquisition. Olof Enqvist: Methodology, Software, Writing - Review & Editing. Reza Kaboteh: Resources, Writing - Review & Editing. Elin Trägårdh: Project administration, Funding acquisition, Writing - Review & Editing. Johannes Ulén: Methodology, Software, Formal analysis, Writing - Review & Editing. Henrik Kjölhede: Conceptualization, Formal analysis, Investigation, Supervision, Writing - Original Draft, Writing - Review & Editing.
Conflicts of interest
The authors declare no competing interests. None of the components in recomia. org are patented. The platform is free to use for scientific purposes in collaboration with the foundation.
Acknowledgments
ORCID Thomas Ying: 0000-0001-8845-8304. Pablo Borrelli: 0000-0002-1665-7088. Lars Edenbrandt: 0000-0002-0263-8820. Olof Enqvist: 0000-0002-7456-1009. Reza Kaboteh: 0000-0001-7552-5109. Elin Trägårdh: 0000-0002-7116-303X. Johannes Ulén: 0000-0003-1625-8367. Henrik Kjölhede: 0000-0001-6441-4729.
Footnotes
Peer review under responsibility of The Korean Society of Osteoporosis.
Supplementary data to this article can be found online at https://doi.org/10.1016/j.afos.2024.04.001.
Appendix A. Supplementary data
The following is the Supplementary data to this article:
References
- 1.Ying T., Borrelli P., Edenbrandt L., Enqvist O., Kaboteh R., Tragardh E., et al. Automated artificial intelligence-based analysis of skeletal muscle volume predicts overall survival after cystectomy for urinary bladder cancer. Eur Radiol Exp. 2021;5(1):50. doi: 10.1186/s41747-021-00248-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kuroki L.M., Mangano M., Allsworth J.E., Menias C.O., Massad L.S., Powell M.A., et al. Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancer. Ann Surg Oncol. 2015;22(3):972–979. doi: 10.1245/s10434-014-4040-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Beumer B.R., van Vugt J.L.A., Sapisochin G., Yoon P., Bongini M., Lu D., et al. Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria. J Cachexia Sarcopenia Muscle. 2022;13(5):2373–2382. doi: 10.1002/jcsm.13053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Au P.C., Li H.L., Lee G.K., Li G.H., Chan M., Cheung B.M., et al. Sarcopenia and mortality in cancer: a meta-analysis. Osteoporos Sarcopenia. 2021;7(Suppl 1):S28–S33. doi: 10.1016/j.afos.2021.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Shen W., Punyanitya M., Wang Z., Gallagher D., St-Onge M.P., Albu J., et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol. 2004;97(6):2333–2338. doi: 10.1152/japplphysiol.00744.2004. [DOI] [PubMed] [Google Scholar]
- 6.Walowski C.O., Braun W., Maisch M.J., Jensen B., Peine S., Norman K., et al. Reference values for skeletal muscle mass - current concepts and methodological considerations. Nutrients. 2020;12(3):755. doi: 10.3390/nu12030755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Schweitzer L., Geisler C., Pourhassan M., Braun W., Gluer C.C., Bosy-Westphal A., et al. Estimation of skeletal muscle mass and visceral adipose tissue volume by a single magnetic resonance imaging slice in healthy elderly adults. J Nutr. 2016;146(10):2143–2148. doi: 10.3945/jn.116.236844. [DOI] [PubMed] [Google Scholar]
- 8.Vangelov B., Bauer J., Kotevski D., Smee R.I. The use of alternate vertebral levels to L3 in computed tomography scans for skeletal muscle mass evaluation and sarcopenia assessment in patients with cancer: a systematic review. Br J Nutr. 2022;127(5):722–735. doi: 10.1017/S0007114521001446. [DOI] [PubMed] [Google Scholar]
- 9.Nemec U., Heidinger B., Sokas C., Chu L., Eisenberg R.L. Diagnosing sarcopenia on thoracic computed tomography: quantitative assessment of skeletal muscle mass in patients undergoing transcatheter aortic valve replacement. Acad Radiol. 2017;24(9):1154–1161. doi: 10.1016/j.acra.2017.02.008. [DOI] [PubMed] [Google Scholar]
- 10.Dennis R.A., Long D.E., Landes R.D., Padala K.P., Padala P.R., Garner K.K., et al. Tutorial for using SliceOmatic to calculate thigh area and composition from computed tomography images from older adults. PLoS One. 2018;13(10) doi: 10.1371/journal.pone.0204529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.MacKeith S.A.C., Das T., Graves M., Patterson A., Donnelly N., Mannion R., et al. A comparison of repeatability and usability of semi-automated volume segmentation tools for measurement of vestibular schwannomas. Otol Neurotol. 2018;39(6):e496–e505. doi: 10.1097/MAO.0000000000001796. [DOI] [PubMed] [Google Scholar]
- 12.Rollins K.E., Awwad A., Macdonald I.A., Lobo D.N. A comparison of two different software packages for analysis of body composition using computed tomography images. Nutrition. 2019;57:92–96. doi: 10.1016/j.nut.2018.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.van Vugt J.L., Levolger S., Gharbharan A., Koek M., Niessen W.J., Burger J.W., et al. A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients. J Cachexia Sarcopenia Muscle. 2017;8(2):285–297. doi: 10.1002/jcsm.12158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Borrelli P., Kaboteh R., Enqvist O., Ulen J., Tragardh E., Kjolhede H., et al. Artificial intelligence-aided CT segmentation for body composition analysis: a validation study. Eur Radiol Exp. 2021;5(1):11. doi: 10.1186/s41747-021-00210-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Tragardh E., Borrelli P., Kaboteh R., Gillberg T., Ulen J., Enqvist O., et al. RECOMIA-a cloud-based platform for artificial intelligence research in nuclear medicine and radiology. EJNMMI Phys. 2020;7(1):51. doi: 10.1186/s40658-020-00316-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hittner J.B., May K., Silver N.C. A Monte Carlo evaluation of tests for comparing dependent correlations. J Gen Psychol. 2003;130(2):149–168. doi: 10.1080/00221300309601282. [DOI] [PubMed] [Google Scholar]
- 17.Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–310. [PubMed] [Google Scholar]
- 18.Derstine B.A., Holcombe S.A., Ross B.E., Wang N.C., Su G.L., Wang S.C. Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population. Sci Rep. 2018;8(1) doi: 10.1038/s41598-018-29825-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Matsuyama R., Maeda K., Yamanaka Y., Ishida Y., Nonogaki T., Kato R., et al. Evaluation of skeletal muscle mass using prediction formulas at the level of the 12th thoracic vertebra. Nutrition. 2022;93 doi: 10.1016/j.nut.2021.111475. [DOI] [PubMed] [Google Scholar]
- 20.Li H.L., Au P.C., Lee G.K., Li G.H., Chan M., Cheung B.M., et al. Different definition of sarcopenia and mortality in cancer: a meta-analysis. Osteoporos Sarcopenia. 2021;7(Suppl 1):S34–S38. doi: 10.1016/j.afos.2021.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.